News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitcoin back to record fear levels as it wipes weekend gains2The Funding: Why TradFi giants like BlackRock are buying DeFi tokens now3Will Solana fall another 95%? Why SOL’s bottom looks far away
Crypto Exchange Backpack Plans to Offer Company Equity to Token Stakers
101 finance·2026/02/23 22:36
Dragonfly’s Qureshi says crypto built for AI
Grafa·2026/02/23 22:33
Anthony Pompliano's Bitcoin Treasury ProCap Buys Back Stock Amid 85% Price Plunge
Decrypt·2026/02/23 22:29
JBT: Q4 Financial Results Overview
101 finance·2026/02/23 22:21
Ryman Hospitality Properties: Fourth Quarter Earnings Overview
101 finance·2026/02/23 22:21
Paramount submits higher offer for Warner Bros Discovery in bid to block Netflix, source says
101 finance·2026/02/23 22:12
Paramount submits higher offer for Warner Bros Discovery in bid to block Netflix, source says
101 finance·2026/02/23 22:09
Flash
22:37
ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.It is currently expected that in the second half of 2026, the Advanced-3 phase registration clinical trial for BCG treatment-naïve patient groups will be officially launched. The initiation of this trial is an important milestone in the company's drug development pathway, marking another key step forward for its core candidate product towards potential approval and market launch.
22:35
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Oric Pharmaceuticals Inc. (ORIC) has announced the launch of an equity offering plan.The company will authorize the underwriter Jefferies to periodically issue common stock to the market at appropriate times in the future, with a total fundraising scale of up to $200 million. Such "shelf offering" arrangements provide listed companies with flexible financing channels, allowing them to issue shares in batches according to market conditions and funding needs. This financing plan will support Oric Pharmaceuticals in advancing its pipeline of targeted oncology therapies. By appointing Jefferies as the sales agent, the company can more efficiently seize market windows and optimize its financing structure.
22:35
Diversified Healthcare Trust releases latest performance outlook, expects total revenue (REV) for fiscal year 2026 to grow by approximately 8.0%Meanwhile, the average monthly rate of the company's properties is also expected to increase by approximately 5.3%. This growth trend reflects the company's robust operations and continuous expansion capabilities in the healthcare real estate sector.
News